51 JFK Parkway, Short Hills, NJ 07078
Category

Healthcare Fraud Defense

Federal and state investigations, False Claims Act defense, and criminal healthcare fraud cases.

Page 18 of 27 · 240 articles
Risk Adjustment Fraud and the FCA
Healthcare Fraud Defense

Risk Adjustment Fraud and the FCA

DOJ's 2026 Medicare Advantage settlements show how unsupported HCC codes and one-sided chart reviews become False Claims Act liabi…

Anthony MahajanSep 4, 2026
Medical Directorship Agreements Under Kickback Scrutiny
Healthcare Fraud Defense

Medical Directorship Agreements Under Kickback Scrutiny

A medical directorship survives Anti-Kickback Statute scrutiny only when compensation reflects fair market value for services actu…

Anthony MahajanSep 4, 2026
Living Under a Corporate Integrity Agreement
Healthcare Fraud Defense

Living Under a Corporate Integrity Agreement

A Corporate Integrity Agreement's real work starts at settlement: IRO reviews, a 30-day Reportable Event clock, and stipulated pen…

Anthony MahajanSep 4, 2026
Reverse False Claims Liability for Retaining an Overpayment
Healthcare Fraud Defense

Reverse False Claims Liability for Retaining an Overpayment

Retaining a known Medicare or Medicaid overpayment past the 60-day deadline can itself be a False Claims Act violation under the r…

Anthony MahajanSep 4, 2026
Medically Unnecessary Services as an FCA Theory
Healthcare Fraud Defense

Medically Unnecessary Services as an FCA Theory

Medical necessity splits the federal circuits on what counts as false under the FCA, turning a documented clinical judgment into t…

Anthony MahajanSep 3, 2026
Materiality as a Defense: Government Knowledge
Healthcare Fraud Defense

Materiality as a Defense: Government Knowledge

Escobar made FCA materiality a demanding standard. Continued government payment despite knowledge of a violation is very strong ev…

Anthony MahajanSep 3, 2026
Laboratory Kickback Enforcement: Process and Handling Fees
Healthcare Fraud Defense

Laboratory Kickback Enforcement: Process and Handling Fees

Specimen processing fees look like overhead reimbursement, but the OIG's 2014 alert and $48.5M in DOJ settlements show how they be…

Anthony MahajanSep 3, 2026
Individual Accountability in Corporate Healthcare Cases
Healthcare Fraud Defense

Individual Accountability in Corporate Healthcare Cases

DOJ's March 2026 Department-wide Corporate Enforcement Policy keeps individual prosecution the priority in corporate healthcare fr…

Anthony MahajanSep 3, 2026
Insurance Coverage for FCA Defense Costs
Healthcare Fraud Defense

Insurance Coverage for FCA Defense Costs

A civil investigative demand can trigger D&O coverage before a lawsuit is filed. What a policy actually pays for, and what it excl…

Anthony MahajanSep 2, 2026